Cogent Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cogent Biosciences using advanced sorting and filters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-03 | $-0.50 | $-0.52 | 3.85 % |
| Q2 | 2025-08-05 | $-0.53 | $-0.57 | 7.02 % |
| Q1 | 2025-05-06 | $-0.52 | $-0.58 | 10.3 % |
| Q4 | 2025-02-25 | $-0.09 | $-0.58 | 84.5 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
Cogent Biosciences (COGT) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on November 3, 2025 for Q3.
The Actual EPS was $-0.50, which beat the estimate of $-0.52.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.